Close Menu

NEW YORK (GenomeWeb) – UgenTec announced today that it has raised $9.3 million in a Series A funding round.

The firm said that it will use the funding to consolidate its position in clinical diagnostics, establish a US office, and enter new diagnostic markets.

"With this financing round, we will consolidate our leading position in clinical diagnostics, set up an office in the United States, and expand into the food safety and quality, agriculture, and animal health [markets]," UgenTec CEO Steven Verhoeven said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.